In ACC, a study revealed a previously uncharacterized CSC population with neural stem cell (NSC) properties expressing SRY-box transcription factor 10 (SOX10), a marker of the gliogenesis and maintenance of adult NSCs and other neural differentiation factors, such as notch receptor 1 (NOTCH1) and fatty acid binding protein 7 (FABP7) [97]. The gene discussed is SOX10; the disease is adrenal cortex carcinoma.